Ketamine use in chronic pain unsupported by evidence
The off-label use of ketamine to treat chronic pain is not supported by scientific evidence, a new Cochrane review has found.
Ketamine is an anaesthetic commonly used for procedural sedation and short-term pain relief. Ketamine is also frequently prescribed off-label to manage chronic pain conditions such as nerve pain, fibromyalgia and complex regional pain syndrome. It is one of several NMDA receptor antagonists — a group of drugs thought to reduce pain by blocking certain brain receptors involved in pain signalling.
The review, conducted by researchers from UNSW Sydney , ...